Full-field electroretinography, visual acuity and visual fields in Usher syndrome: a multicentre European study.
ERG
Functional diagnostics
Usher syndrome
Visual acuity
Visual field
Journal
Documenta ophthalmologica. Advances in ophthalmology
ISSN: 1573-2622
Titre abrégé: Doc Ophthalmol
Pays: Netherlands
ID NLM: 0370667
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
24
01
2019
accepted:
19
06
2019
pubmed:
4
7
2019
medline:
23
11
2019
entrez:
4
7
2019
Statut:
ppublish
Résumé
Usher syndrome (USH) is a multisensory deficiency involving vision, hearing and the vestibular system. The purpose of this study is to report on the functional data (i.e. electroretinography, visual fields, visual acuity) of patients with retinitis pigmentosa (RP) due to Usher syndrome that were collected in a multicentre European study (TREATRUSH). A total of 268 genetically confirmed USH patients underwent electrophysiological examinations in the context of multimodal ophthalmological examination in the study (75 USH1, 189 USH2 and four USH3). Full-field electroretinography (ERG) was performed according to ISCEV standards, visual field determination was carried out with either the Octopus or Goldmann perimeters and visual acuity was examined with either ETDRS or Snellen charts. The data were compared between USH subtypes (USH1/USH2/USH3) and correlated with age. Visual acuity decreases significantly with age for both USH1 and USH2 (p < 0.001), without a difference between the two cohorts. When corrected for age, the preserved kinetic visual field was significantly larger in USH2 than in USH1 (p = 0.04). Furthermore, the preserved kinetic visual field area showed a significant decrease with age (based on an exponential fit) in both USH1 and USH2 (p < 0.001). In USH1 patients, however, the visual field was already vastly reduced at an early age. The ERG results were abnormal in all patients. Detectable data for scotopic ERG were obtained from nine patients, and data of photopic ERG were obtained from 24 patients, without a difference between USH1 and USH2 subtypes. There are differences in the phenotypes of RP in USH subtypes, most visible in the progression of visual fields between USH1 and USH2. The perimetric reduction occurs earlier in USH1 than in USH2. In both subtypes, visual acuity decreases significantly with age and the ERG is not detectable already at early ages.
Identifiants
pubmed: 31267413
doi: 10.1007/s10633-019-09704-8
pii: 10.1007/s10633-019-09704-8
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
151-160Références
Am J Med Genet. 1996 Sep 6;64(4):602-3
pubmed: 8870929
Trans Am Ophthalmol Soc. 2000;98:237-42; discussion 243-5
pubmed: 11190026
Trans Am Ophthalmol Soc. 2009 Dec;107:311-24
pubmed: 20126505
Klin Monbl Augenheilkd. 2005 Mar;222(3):186-90
pubmed: 15785977
Ophthalmology. 2016 May;123(5):1151-60
pubmed: 26927203
Arch Ophthalmol. 1998 Feb;116(2):165-8
pubmed: 9488267
Annu Rev Genomics Hum Genet. 2001;2:271-97
pubmed: 11701652
Retina. 2017 Aug;37(8):1581-1590
pubmed: 27828912
Int Ophthalmol. 1995-1996;19(5):307-11
pubmed: 8864816
J Cell Biol. 2017 Jun 5;216(6):1849-1864
pubmed: 28495838
Hum Mol Genet. 2008 Jan 1;17(1):71-86
pubmed: 17906286
Invest Ophthalmol Vis Sci. 2014 Nov 25;56(1):107-14
pubmed: 25425308
Sci Rep. 2017 Sep 11;7(1):11170
pubmed: 28894305
Adv Exp Med Biol. 2003;533:123-31
pubmed: 15180256
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5532-9
pubmed: 18641288
Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1462-9
pubmed: 9660495
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4413-8
pubmed: 17360538
Arq Bras Oftalmol. 2005 Mar-Apr;68(2):171-6
pubmed: 15905936
PLoS Genet. 2010 May 20;6(5):e1000955
pubmed: 20502675
Acta Ophthalmol Scand. 2004 Apr;82(2):131-9
pubmed: 15043528
Vision Res. 2012 Dec 15;75:60-70
pubmed: 23000274
Ophthalmology. 2014 Feb;121(2):580-7
pubmed: 24199935
Invest Ophthalmol Vis Sci. 2004 Mar;45(3):784-92
pubmed: 14985291
Acta Ophthalmol Scand. 2002 Apr;80(2):196-201
pubmed: 11952489
Eur J Ophthalmol. 2011 Jan-Feb;21(1):30-8
pubmed: 20544672
J Cell Biol. 2012 Oct 15;199(2):381-99
pubmed: 23045546
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4664-71
pubmed: 18566474
Eur J Hum Genet. 2016 Dec;24(12):1730-1738
pubmed: 27460420
J Med Genet. 2003 Oct;40(10):767-72
pubmed: 14569126